Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-17 8:20 pm Purchase | 2025-12-11 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 31,353 4.990% | 31,353 (New Position) | Filing History |
| 2025-12-10 3:47 pm Sale | 2025-12-09 | 13G | Enveric Biosciences, Inc. ENVB | Braeden Lichti | 0 0.000% | -29,920 (Position Closed) | Filing History |
| 2025-12-10 3:47 pm Sale | 2025-12-09 | 13G | Enveric Biosciences, Inc. ENVB | Northstrive Fund II LP | 0 0.000% | -29,920 (Position Closed) | Filing History |
| 2025-12-05 7:06 pm Purchase | 2025-12-03 | 13G | Enveric Biosciences, Inc. ENVB | Braeden Lichti | 29,920 5.010% | 29,920 (New Position) | Filing History |
| 2025-12-05 5:40 pm Purchase | 2025-12-03 | 13G | Enveric Biosciences, Inc. ENVB | Northstrive Fund II LP | 29,920 5.010% | 29,920 (New Position) | Filing History |
| 2025-11-13 3:42 pm Purchase | 2025-09-30 | 13G | Enveric Biosciences, Inc. ENVB | Ayrton Capital LLC | 658,465 9.990% | 658,465 (New Position) | Filing History |
| 2025-10-03 5:51 pm Purchase | 2025-09-30 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 16,973 6.270% | 9,446 (+125.50%) | Filing History |
| 2025-09-24 5:17 pm Sale | 2025-09-18 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 1,611 0.400% | -7,051 (-81.40%) | Filing History |
| 2025-04-02 4:12 pm Purchase | 2025-03-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 7,527 3.650% | 7,305 (+3287.97%) | Filing History |
| 2025-02-05 5:15 pm Purchase | 2025-01-30 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 8,663 4.990% | 8,663 (New Position) | Filing History |
| 2025-02-04 7:51 pm Sale | 2025-01-31 | 13G | Enveric Biosciences, Inc. ENVB | Orca Capital AG | 8,085 4.900% | -5,804 (-41.79%) | Filing History |
| 2025-02-04 7:47 pm Purchase | 2025-01-30 | 13G | Enveric Biosciences, Inc. ENVB | Orca Capital AG | 13,889 8.700% | 13,889 (New Position) | Filing History |
| 2025-01-06 5:04 pm Purchase | 2024-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 222 5.900% | 86 (+63.43%) | Filing History |
| 2024-11-14 4:03 pm Sale | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | Armistice Capital, LLC | 0 0.000% | -101 (Position Closed) | Filing History |
| 2024-11-13 11:18 am Purchase | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 107 3.100% | 54 (+100.00%) | Filing History |
| 2024-11-12 1:43 pm Purchase | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 136 4.110% | 93 (+215.62%) | Filing History |
| 2024-02-14 3:36 pm Purchase | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Armistice Capital, LLC | 101 9.990% | 101 (New Position) | Filing History |
| 2024-02-06 10:17 am Sale | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 54 6.200% | -23 (-29.66%) | Filing History |
| 2024-02-05 5:09 pm Unchanged | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Hudson Bay Capital Management LP | 41 4.540% | 0 (Unchanged) | Filing History |
| 2023-02-14 5:02 pm Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | AdvisorShares Trust | 43 5.600% | 43 (New Position) | Filing History |